Recombinant AAV (rAAV) manufacturing is composed of four main components which include a rep/cap plasmid, a helper plasmid, a transgene plasmid, and a viral packaging cell line. Triple transfection of the three plasmids into HEK293 cells is the most frequently used rAAV production method.
In stock, royalty-free, helper plasmid solution for recombinant AAV manufacturing.
In stock, royalty-free, helper plasmid solution for recombinant AAV manufacturing.
Our rep/cap plasmids provide the appropriate packaging functions for AAV-based gene therapeutics.
Our ITR reporter plasmids and cloning vectors are available for AAV-based gene therapeutics.
Acquisition combines Aldevron's leadership in GMP manufacturing with Nature Tech's portfolio of proprietary technologies. Aldevron has acquired...
Aldevron is now offering its pALD-HELP, an off-the-shelf product supporting AAV viral vector manufacturing, in its proprietary GMP-Source® (GMP-S)...
Aldevron announced today it is now offering pALD-HELP to support AAV viral vector manufacturing. This additional Ad helper plasmid is immediately...
Overcoming challenges, increasing yields In efforts to bring the next-generation of plasmid technology to the cell and gene therapy space, Aldevron...
Advantages of the Nanoplasmid RNA-OUT Marker System For decades, the same plasmid technology has been used in vaccination, cell and gene therapy, and...
Downstream challenges in mRNA production In my previous post, I brought up important questions that should be asked when beginning to design a...
